CapsoVision Inc (CV)

Currency in USD
6.15
-0.30(-4.58%)
Closed·
6.24+0.09(+1.46%)
·

CV Earnings

Latest Release
Aug 13, 2026
EPS / Forecast
-0.15 / -0.11
Revenue / Forecast
3.6M / --
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
09/2026--/-0.110--/------Free Sign Up
06/2026-0.150/-0.1103.60M/---36.36%--Free Sign Up
03/2026-0.150/-0.1102.80M/---36.36%--Free Sign Up
12/2025-0.160/-0.1003.90M/---60%--Free Sign Up
09/2025-0.170/--3.54M/------Free Sign Up
06/2025-2.02/--3.32M/------Free Sign Up
03/2025-2.49/--2.79M/------Free Sign Up

All numbers in USD

CapsoVision Inc Earnings Call Summary for Q2/2026

  • Q2 revenue rose 10% YoY to $3.6M, but EPS of -$0.15 missed estimates by $0.04, triggering a 7.7% after-hours stock decline to $6.27.
  • Gross margin compressed to 51% from 55% due to pricing pressure and tariffs; operating expenses surged 46% to $9.5M on R&D and public company costs.
  • Management expects H2 2026 to outpace H1, with Q4 as strongest quarter; FDA clearance for AI Highlights anticipated by end of Q3 2026.
  • CapsoCam Colon FDA submission delayed one quarter to Q4 2026; company maintains $100M ATM program amid $9.1M cash position and rising capital needs.
  • CEO Wang cited 176K patients imaged globally, up 23% YoY, positioning AI-assisted panoramic imaging as key competitive differentiator for future growth.
Last Updated: 08/14/2026, 05:18 AM
Read Full Transcript

FAQ

What Is CapsoVision's Earnings Per Share (TTM)?

The CapsoVision EPS (TTM) is -0.62.

When Is The Next CapsoVision Earnings Date?

CapsoVision will release its next earnings report on Nov 12, 2026.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.